Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernardo Bonanni

Showing results (121-130 of 265) with videos related to

Pageof 27
Sort By:
Critical Reviews in Oncology/Hematology|November 19, 2018
A rationale multidisciplinary approach for treatment of esophageal and gastroesophageal junction cancer: Accurate review of management and perspectivesAntonio Chiappa, Bruno Andreoni, Renzo Dionigi, et al.
Genes|January 25, 2025
Hereditary Breast Cancer: Comprehensive Risk Assessment and Prevention StrategiesEliza Del Fiol Manna, Davide Serrano, Laura Cazzaniga, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2004
A two-by-two factorial trial comparing oral with transdermal estrogen therapy and fenretinide with placebo on breast cancer biomarkersAndrea Decensi, Bernardo Bonanni, Laura Baglietto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2009
Randomized double-blind 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in high-risk premenopausal womenAndrea Decensi, Chris Robertson, Aliana Guerrieri-Gonzaga, et al.
JAMA Network Open|July 8, 2026
Germline Multigene Panel Testing in Women With Invasive Lobular CancerGiovanni Corso, Elena Marino, Francesca Fava, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 13, 2021
Advances and controversies in management of breast ductal carcinoma in situ (DCIS)Gabriel Farante, Antonio Toesca, Francesca Magnoni, et al.
Journal of the National Cancer Institute|August 29, 2025
Effect of low-dose tamoxifen on benign gynecological and breast conditions in a phase III trial in non-invasive breast cancerAlessio Carbone, Martino Oliva, Matteo Puntoni, et al.
Clinical Epigenetics|December 18, 2021
An epigenetic aging analysis of randomized metformin and weight loss interventions in overweight postmenopausal breast cancer survivorsJamaji C Nwanaji-Enwerem, Felicia Fei-Lei Chung, Lars Van der Laan, et al.
Scientific Reports|May 15, 2025
Effects of metformin on transcriptomic and metabolomic profiles in breast cancer survivors enrolled in the randomized placebo-controlled MetBreCS trialPouda Panahandeh Strømland, Bjørn-Erik Bertelsen, Kristin Viste, et al.
Lancet (London, England)|May 4, 2013
Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant dataJack Cuzick, Ivana Sestak, Bernardo Bonanni, et al.
Pageof 27

Showing results (121-130 of 265) with videos related to

Sort By:
Pageof 27
Critical Reviews in Oncology/Hematology|November 19, 2018
A rationale multidisciplinary approach for treatment of esophageal and gastroesophageal junction cancer: Accurate review of management and perspectivesAntonio Chiappa, Bruno Andreoni, Renzo Dionigi, et al.
Genes|January 25, 2025
Hereditary Breast Cancer: Comprehensive Risk Assessment and Prevention StrategiesEliza Del Fiol Manna, Davide Serrano, Laura Cazzaniga, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2004
A two-by-two factorial trial comparing oral with transdermal estrogen therapy and fenretinide with placebo on breast cancer biomarkersAndrea Decensi, Bernardo Bonanni, Laura Baglietto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2009
Randomized double-blind 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in high-risk premenopausal womenAndrea Decensi, Chris Robertson, Aliana Guerrieri-Gonzaga, et al.
JAMA Network Open|July 8, 2026
Germline Multigene Panel Testing in Women With Invasive Lobular CancerGiovanni Corso, Elena Marino, Francesca Fava, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 13, 2021
Advances and controversies in management of breast ductal carcinoma in situ (DCIS)Gabriel Farante, Antonio Toesca, Francesca Magnoni, et al.
Journal of the National Cancer Institute|August 29, 2025
Effect of low-dose tamoxifen on benign gynecological and breast conditions in a phase III trial in non-invasive breast cancerAlessio Carbone, Martino Oliva, Matteo Puntoni, et al.
Clinical Epigenetics|December 18, 2021
An epigenetic aging analysis of randomized metformin and weight loss interventions in overweight postmenopausal breast cancer survivorsJamaji C Nwanaji-Enwerem, Felicia Fei-Lei Chung, Lars Van der Laan, et al.
Scientific Reports|May 15, 2025
Effects of metformin on transcriptomic and metabolomic profiles in breast cancer survivors enrolled in the randomized placebo-controlled MetBreCS trialPouda Panahandeh Strømland, Bjørn-Erik Bertelsen, Kristin Viste, et al.
Lancet (London, England)|May 4, 2013
Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant dataJack Cuzick, Ivana Sestak, Bernardo Bonanni, et al.
Pageof 27